A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/28/1999	WO1999054359A1 Matrix binding factor
10/28/1999	WO1999054358A1 Melanocortin receptor ligands
10/28/1999	WO1999054357A1 Novel cytokine-like protein
10/28/1999	WO1999054356A1 Peptide fragments of murine epidermal growth factor as laminin receptor targets
10/28/1999	WO1999054354A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
10/28/1999	WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999	WO1999054352A2 Srebp-1 and srebp-2 in a phosphorylated form
10/28/1999	WO1999054351A1 Edg family gene, human h218
10/28/1999	WO1999054350A1 Novel omega conotoxin peptides
10/28/1999	WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	WO1999054346A1 Glutathione derivatives and dosage forms thereof
10/28/1999	WO1999054345A1 Cd8 antagonists
10/28/1999	WO1999054341A1 Enhanced antisense modulation of icam-1
10/28/1999	WO1999054317A1 Cysteine protease inhibitors
10/28/1999	WO1999053961A1 Peptides for efficient gene transfer
10/28/1999	WO1999053959A2 Use of viral vectors for treatment of the injured peripheral and central nervous system
10/28/1999	WO1999053958A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999	WO1999053954A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
10/28/1999	WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999	WO1999053949A2 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	WO1999053944A1 Method for treating the endotoxic shock in mammals
10/28/1999	WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999	WO1999053942A1 Compositions comprising osteoprotegerin for the prevention and treatment of cardiovascular diseases
10/28/1999	WO1999053941A1 Oral preparations containing trh derivatives
10/28/1999	WO1999053940A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
10/28/1999	WO1999053939A1 Treatment of osteoporosis with leptin
10/28/1999	WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999	WO1999053900A1 Drug delivery of proteins from polymeric blends
10/28/1999	WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999	WO1999043308A3 Treating pulmonary hypertension through tenascin suppression and elastase inhibition
10/28/1999	WO1999042580A8 Gaba receptors and their uses
10/28/1999	WO1999042127A3 Receptor derived peptides as modulators of receptor activity
10/28/1999	WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999	WO1999041279A3 Methods and compositions comprising the use of blocked b-amyloid peptide
10/28/1999	WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999	WO1999040112A9 Neuroprotective peptides and uses thereof
10/28/1999	WO1999039740A3 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
10/28/1999	WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999	WO1999036441A3 Haemopoietic stem cell inhibitor(s)
10/28/1999	WO1999036092A3 Hiv inhibition using ligand for gp60 receptor or albumin receptor on target cells
10/28/1999	WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999	WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999	WO1999029341A3 Methods for enhancement of protective immume responses employing leishmania polypeptides
10/28/1999	WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999	WO1999024463A3 Signal peptide-containing proteins
10/28/1999	WO1999024460B1 Dipeptide nitriles
10/28/1999	WO1999008695A8 FLUORESCENT AMYLOID Aβ PEPTIDES AND USES THEREOF
10/28/1999	WO1999005272A9 Use of transcription factor brn-3a
10/28/1999	WO1998044104A3 Flip gene and flip protein
10/28/1999	DE19903693A1 Protease zur Aktivierung des Gerinnungsfaktors VII Protease for activation of coagulation factor VII
10/28/1999	DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999	DE19817118C1 New nucleic acid encoding human dyskerin, for diagnosis, treatment and prevention of dyskeratosis congenita and for stabilizing chromosomes
10/28/1999	DE19816902A1 New phosphorylated forms of sterol regulatory element binding proteins useful for treating or preventing arteriosclerosis, stroke and diabetes mellitus
10/28/1999	CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	CA2329712A1 Cysteine protease inhibitors
10/28/1999	CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999	CA2328774A1 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf)
10/28/1999	CA2328731A1 Glutathione derivatives and dosage forms thereof
10/28/1999	CA2328463A1 Matrix binding factor
10/28/1999	CA2328399A1 Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor
10/28/1999	CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999	CA2326823A1 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
10/28/1999	CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999	CA2326406A1 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	CA2326384A1 Canine erythropoietin gene and recombinant protein
10/28/1999	CA2325871A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep
10/28/1999	CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999	CA2325848A1 B-cell growth factor related protein
10/28/1999	CA2325822A1 Soluble protein ztmpo-1
10/28/1999	CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression
10/28/1999	CA2325573A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999	CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999	CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/28/1999	CA2294980A1 Method for the treatment of endotoxic shock in mammels
10/28/1999	CA2270320A1 Novel microsphere composition
10/28/1999	CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999	EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
10/27/1999	EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999	EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999	EP0952217A2 Use of a recombinant protein as receptor of a hepatitis virus
10/27/1999	EP0952215A2 Protease for activating clotting factor VII
10/27/1999	EP0952171A2 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
10/27/1999	EP0952159A2 Use of somatostatin derivatives and/or of phenylhydrazone derivatives as antinflammatory or analgetic agents
10/27/1999	EP0951917A2 Particle delivery of particularly a powdered therapeutical agent
10/27/1999	EP0951911A2 Method for administering aspb28-human insulin
10/27/1999	EP0951910A2 Method for administering monomeric insulin analogs
10/27/1999	EP0951842A2 Infant formula
10/27/1999	EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase
10/27/1999	EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999	EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999	EP0951553A2 Adenovirus e4 proteins for inducing cell death
10/27/1999	EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999	EP0951550A1 Mammalian cytokine related to il10
10/27/1999	EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors
10/27/1999	EP0951545A2 Human gtp-binding proteins
10/27/1999	EP0951544A2 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
10/27/1999	EP0951543A1 Human glycine transporter

1 ... 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 ... 3163